BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Piramal Enterprises Limited
sales of 51.23 billion Indian Rupees [US$803.23 million]
Torrent Pharmaceuticals Limited
(46.53 billion Indian Rupees [US$729.59 million]
Kaken Pharmaceutical Co Ltd
(93.89 billion Japanese Yen [US$778.34 million]
BML Inc reported sales of ¥104.40 billion (US$865.51 million)
March of 2015.
increase of 5.4%
versus 2014, when the company's sales were ¥99.05 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 32%).